Pembrolizumab and External Beam Radiation Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
H. Lee Moffitt Cancer Center and Research Institute
Case Comprehensive Cancer Center
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
Masonic Cancer Center, University of Minnesota
Wake Forest University Health Sciences
Fondazione Italiana Linfomi - ETS
SecuraBio
M.D. Anderson Cancer Center
BeiGene
Emergent BioSolutions
Stanford University
City of Hope Medical Center
University of Nebraska
Dana-Farber Cancer Institute
miRagen Therapeutics, Inc.
Brown University
National Institutes of Health Clinical Center (CC)
Stanford University
Eli Lilly and Company
Mayo Clinic
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
Celgene
Fred Hutchinson Cancer Center
Acrotech Biopharma Inc.
Celgene
Fred Hutchinson Cancer Center
Fondazione Italiana Linfomi - ETS
Takeda
University of Michigan Rogel Cancer Center
National Institutes of Health Clinical Center (CC)
Massachusetts General Hospital
Dana-Farber Cancer Institute
University of Rochester
Seagen Inc.
Rigel Pharmaceuticals
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center